« Back
Home /
Anti-Apolipoprotein C-I (Human)

Anti-Apolipoprotein C-I (Human)

Manufacturer	GENWAY
Category	Antibodies Immunohistochemistry Immunoprecipitation Western Blot ELISA Primary Antibodies
Type	Antibody
Specific against	Human
Applications	WB, IP, IHC, ELISA
Amount	1 mg
Item no.	18-732-292281
eClass 6.1	32160702
eClass 9.0	32160702
Available
Genway ID:	GWB-925296
Antigen:	apoLipoprotein C1
Immunogen:	apoLipoprotein Type C-I produced synthetically in full-length form (not selected epitopes) using conventional peptide technology. Family: ApolipoproteinFraction: Affinity Purified IgGApplication: Anti-apoLipoprotein antibodies have been used for indirect trapping ELISA for quantitation of antigen in serum using a standard curve for immunoprecipitation and for western blotting for highly sensitive qualitative analysis. Recommended
Dilution:	This product was assayed by immunoblot and found to be reactive against apoLipoprotein C-I at a dilution of 1:5 000 to 1:10 000. This product was also assayed against 1. 0 ug of apoLipoprotein C-I in a standard sandwich ELISA using Peroxidase conjugated Affinity Purified anti-Goat IgG [H& L] (Rabbit) catalog # 25-732-294061 and (ABTS (2 2\' -azino-bis-[3-ethylbenthiazoline-6-sulfonic acid]) as a substrate for 30 minutes at room temperature. A working dilution of 1:4 000 to 1:8 000 of the stock concentration is suggested for this product. For immunohistochemistry on paraffin embedded tissue dilute the product 1:50 to 1:200. Optimal titers for other applications should be determined by the researcher. Physical State: Liquid (sterile filtered)Purity and
Specificity:	This product has been prepared by immunoaffinity chromatography using immobilized antigens followed by extensive cross-adsorption against other apoLipoproteins and human serum proteins to remove any unwanted specificities. Typically less than 1% cross reactivity against other types of apoLipoprotein was detected by ELISA against purified standards. This antibody reacts with human apoLipoprotein C-I and has negligible cross-reactivity with Type A-I A-II B C-II C-III E and J apoLipoproteins. Specific cross reaction of anti-apoLipoprotein antibodies with antigens from other species has not been determined. Non-specific cross reaction of anti-apoLipoprotein antibodies with other human serum proteins is negligible. Antibody
Concentration:	1. 0 mg/ml (by UV absorbance at 280 nm)
Buffer:	1. 0 mg/ml (by UV absorbance at 280 nm)
Stabilizer:	None
Ship Code:	WETICE
Function:	Appears to modulate the interaction of APOE with beta-migrating VLDL and inhibit binding of beta-VLDL to the LDL receptor-related protein.
Subcellular Location:	Secreted.
Tissue Specificity:	Synthesized mainly in liver and to a minor degree in intestine. Secreted in plasma.
Miscellaneous:	Apo-CI makes up about 10% of the protein of the VLDL (very low density lipoprotein) and 2% of that of HDL (high density lipoprotein).
Similarity:	Belongs to the apolipoprotein C1 family.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Delivery expected until 6/13/2024